Table 2.
Comparison of laboratory data of TBE and TBE co-infected (TBE+LD) patients with healthy subjects (CTR).
| CTR | TBE | TBE+LD | |
|---|---|---|---|
| Complete blood count | |||
| WBC [103/μL] | 4.00–10.00 | 10.35 ± 2.27 | 7.41 ± 1.47 |
| Neutrophils [%] | 40.0–72.0 | 70.56 ± 10.21 | 61.2 ± 7.54 |
| Lymphocytes [%] | 18.00–48.00 | 18.8 ± 9.27 | 25.58 ± 4.77 |
| Monocytes [%] | 2.50–10.00 | 9.49 ± 2.68 | 10.86 ± 2.18 |
| RBC [106/μL] | 4.00–5.50 | 4.29 ± 0.33 | 4.33 ± 0.61 |
| HGB [g/dL] | 12.00–16.00 | 12.91 ± 1.08 | 12.74 ± 1.39 |
| PLT [103/μL] | 130–350 | 251 ± 49.17 | 280 ± 57.92 |
| CRP [mg/L] | 0.00–5.00 | 12.16 ± 18.48 | 1.56 ± 1.28 |
| Glucose [mg/dL] | 70–110 | 96 ± 10.47 | 92.67 ± 8.5 |
| Creatinine [mg/dL] | 0.50–0.90 | 0.89 ± 0.17 | 0.79 ± 0.09 |
| ALT [U/I] | 0–31 | 25 ± 27.3 | 17.75 ± 11.27 |
| AST [U/I] | 0–32 | 16.2 ± 7.01 | 17 ± 3.67 |